Dermatologie
Author:
Özistanbullu Deniz
Reference9 articles.
1. Balagula Y, Garbe C, Myskowski PL et al.: Clinical presentation and management of dermatological toxicities of epidermal growth factor receptor inhibitors. International journal of dermatology 50(2) (2011) 129–146. 2. Gutzmer R, Wollenberg A, Ugurel S et al.: Cutaneous side effects of new antitumor drugs: clinical features and management. Dtsch Arztebl Int 109(8) (2012) 133–140. 3. Macdonald JB, Macdonald B, Golitz LE et al.: Cutaneous adverse effects of targeted therapies: Part I: Inhibitors of the cellular membrane. Journal of the American Academy of Dermatology 72(2) (2015) 203–218; quiz 219–220. 4. Macdonald JB, Macdonald B, Golitz LE et al.: Cutaneous adverse effects of targeted therapies: Part II: Inhibitors of intracellular molecular signaling pathways. Journal of the American Academy of Dermatology 72(2) (2015) 221–236; quiz 237–228. 5. Pérez Fidalgo JA, García Fabregat L, Cervantes A et al.: Management of chemotherapy extravasation: ESMO-EONS Clinical Practice Guidelines. Ann Oncol 23 Suppl 7 (2012) vii167–173.
|
|